Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SAVA | US
-0.04
-2.71%
Healthcare
Biotechnology
30/06/2024
24/04/2026
1.61
1.66
1.67
1.60
Cassava Sciences Inc. a clinical stage biotechnology company develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam a small molecule drug which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics Inc. and changed its name to Cassava Sciences Inc. in March 2019. The company was incorporated in 1998 and is based in Austin Texas.
View LessPrice Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
56.4%1 month
52.4%3 months
74.8%6 months
81.9%-
151.51
7.36
-
-
-8.26
-
-
-130.64M
77.48M
77.48M
-
-
-
-
-8.35
9.57
39.21
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.27
Range1M
0.29
Range3M
0.95
Rel. volume
0.87
Price X volume
529.60K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Agenus Inc | AGEN | Biotechnology | 3.9 | 84.13M | 3.72% | n/a | -170.56% |
| Immutep Limited | IMMP | Biotechnology | 0.573 | 84.06M | 0.37% | n/a | 0.51% |
| Gossamer Bio Inc | GOSS | Biotechnology | 0.3627 | 82.05M | -2.92% | n/a | 243.93% |
| CRDF | CRDF | Biotechnology | 1.72 | 80.07M | 2.99% | n/a | 3.52% |
| iShares MSCI Brazil ETF USD Acc | CSBR | Biotechnology | 5.865 | 79.73M | -2.90% | n/a | -2140.66% |
| vTv Therapeutics Inc | VTVT | Biotechnology | 32.76 | 79.70M | -6.00% | n/a | 1.55% |
| Oncolytics Biotech Inc. (USA) | ONCY | Biotechnology | 1.03 | 79.16M | -5.50% | n/a | 0.00% |
| Equillium Inc | EQ | Biotechnology | 2.16 | 76.52M | -0.46% | n/a | 2.71% |
| Fortress Biotech Inc | FBIOP | Biotechnology | 14.25 | 76.49M | 6.26% | n/a | 494.61% |
| XBiotech Inc | XBIT | Biotechnology | 2.51 | 76.46M | -0.79% | n/a | 5.08% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.765 | 73.67M | 1.69% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.9 | 70.43M | 6.56% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 21.77 | 33.16M | -2.81% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.57 | 11.01M | -3.37% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5165 | 7.55M | -0.67% | 0.03 | 16.03% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.38 | 3.52M | 0.23% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.199 | 1.89M | 1.38% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.27 | 699.77K | -6.62% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0055 | 507.18K | -37.50% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.26 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 7.36 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 74.81 | 72.80 | Par |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 77.48M | 3.66B | Emerging |